Brain+ Unveils New Visual Identity and Website, Showcasing Ayla Dementia Care Platform's Scalable Solutions
PorAinvest
viernes, 11 de octubre de 2024, 3:12 am ET1 min de lectura
MIND--
Brain+'s Ayla brand represents hope for improved dementia care, embodying the company's commitment to clinical effectiveness and emotional support. The platform's scalability sets it apart from existing solutions, enabling Brain+ to reach a larger audience and expand its offerings along the patient pathway.
The upcoming product release, Ayla – your Home Companion, scheduled for 2025, is a significant step towards achieving this goal [1]. Ayla is a proprietary software-based solution for highly scalable offerings of Cognitive Stimulation Therapy (CST), a clinically proven interventional therapy for people with dementia [1].
Brain+ is fully on track to release Ayla – your CST Assistant, its first product, as a medical device software on the UK market by the end of September 2024 [1]. The company's product roadmap for 2025 includes three new digital dementia products and services to further broaden its offerings and provide additional support to patients [1].
Devika Wood, Chief Commercial Officer of Brain+, shared her ambition for the company to become a household name for dementia management and treatment [1]. To support this goal, Brain+ is creating a compelling and powerful new brand for Ayla, which will be shared over the coming weeks.
References:
[1] Brain+ A/S. (2024, September 23). Brain+ unveils new products planned for 2025 with next step expansions of its dementia offerings towards building the world's first scalable dementia management platform. https://www.inderes.dk/en/releases/brain-as-brain-informs-of-three-product-releases-planned-for-2025-and-introduces-a-platform-renaming-as-part-of-its-uk-commercialization
Brain+ has introduced a new visual identity and website to promote its Ayla Dementia Care platform, aiming to revolutionize dementia care. The Ayla brand represents hope for improved dementia care, with a scalable platform to offer accessible, engaging, and effective support. The new branding reflects Brain+’s dedication to clinical effectiveness and emotional support, with an upcoming product release, Ayla – your Home Companion, slated for 2025.
In a groundbreaking move, Brain+, a leading player in dementia care solutions, has announced the introduction of a new visual identity and website for its Ayla Dementia Care platform. This innovative platform aims to revolutionize dementia care by offering accessible, engaging, and effective support to those affected by dementia [1].Brain+'s Ayla brand represents hope for improved dementia care, embodying the company's commitment to clinical effectiveness and emotional support. The platform's scalability sets it apart from existing solutions, enabling Brain+ to reach a larger audience and expand its offerings along the patient pathway.
The upcoming product release, Ayla – your Home Companion, scheduled for 2025, is a significant step towards achieving this goal [1]. Ayla is a proprietary software-based solution for highly scalable offerings of Cognitive Stimulation Therapy (CST), a clinically proven interventional therapy for people with dementia [1].
Brain+ is fully on track to release Ayla – your CST Assistant, its first product, as a medical device software on the UK market by the end of September 2024 [1]. The company's product roadmap for 2025 includes three new digital dementia products and services to further broaden its offerings and provide additional support to patients [1].
Devika Wood, Chief Commercial Officer of Brain+, shared her ambition for the company to become a household name for dementia management and treatment [1]. To support this goal, Brain+ is creating a compelling and powerful new brand for Ayla, which will be shared over the coming weeks.
References:
[1] Brain+ A/S. (2024, September 23). Brain+ unveils new products planned for 2025 with next step expansions of its dementia offerings towards building the world's first scalable dementia management platform. https://www.inderes.dk/en/releases/brain-as-brain-informs-of-three-product-releases-planned-for-2025-and-introduces-a-platform-renaming-as-part-of-its-uk-commercialization

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios